GPNMB and hepatocellular carcinoma: GPNMB has been shown to be increased in multiple malignancies, including breast cancer, prostate cancer, glioblastoma multiforme, melanoma, gastric cancer, colorectal carcinoma, small cell lung cancer, renal cell carcinoma, and hepatocellular carcinoma [2–11].